Drug utilization study of mirabegron (Betmiga®) using real-world healthcare databases from the Netherlands, Spain, United Kingdom and Finland (Mirabegron DUS)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Clinical Practice Research Datalink

  The Information System for Research in Primary Care (SIDIAP)

  PHARMO Data Network
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

  Other
• Data sources (types), other:
  The Finnish data sources include the e-Prescription Register, Care Register for Health Care, Register of Primary Health Care Visits, Population Register Centre and Causes of Death Registry of Finland and electronic medical record databases of city of Helsinki, Vantaa and Espoo.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown